ATXI - Why Avenue Therapeutics Shares Are Getting Hammered | Benzinga
Avenue Therapeutics Inc (NASDAQ: ATXI) shares are trading lower by 31% to $0.24 Friday morning after the company announced it has entered into warrant exercise agreements with existing accredited investors.
This involves the immediate exercise of certain outstanding warrants, totaling 16.5 million shares of the company's ...